Nosopharm SAS of France has appointed Jacques Biton and Frédéric Hammel to its supervisory board as it rolls out plans for its pipeline of antimicrobial molecules. Dr Biton is a consultant with Novagreen Conseil, a specialist service company. He brings with him 35 years of experience in the pharmaceutical industry, particularly in antibiotic development. Dr Hammel is a venture partner at Elaia Partners and the chief executive of Ethera, a start-up developing air quality products.
Nosopharm announced the appointments on 5 November 2019.
